Credit: Matt Miller
Graduate student Megan Radyk and Jason Mills, MD, PhD, led a study revealing that although many cancer therapies target rapidly dividing stem cells, mature cells also seem to play a key role in initiating cancer, at least in forming precancerous lesions.